Phase II trial with BCNU plus α-interferon in patients with recurrent high-grade gliomas

1997

Malignant gliomas are primary CNS tumors with a poor prognosis which has not improved recently.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

15

References

36

Citations